Cargando…

Prognostic Significance of Baseline Blood Glucose Levels and Glucose Variability in Severe Acute Kidney Injury: A Secondary Analysis from the RENAL Study

Aim: To study the associations between baseline blood glucose levels (BGL), glycemic variability and clinical outcomes in patients with severe acute kidney injury (AKI) receiving continuous renal replacement therapy (CRRT). Methods: We performed a secondary analysis of the Randomized Evaluation of N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Ying, Lin, Jin, Gallagher, Martin, Bellomo, Rinaldo, Wang, Xia, Jardine, Meg, Duan, Meili, Wang, Amanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821032/ https://www.ncbi.nlm.nih.gov/pubmed/36614814 http://dx.doi.org/10.3390/jcm12010015

Ejemplares similares

A Novel Risk Prediction Model for Severe Acute Kidney Injury in Intensive Care Unit Patients Receiving Fluid Resuscitation
por: Feng, Yunlin, et al.
Publicado: (2022)

Sodium-glucose cotransporter 2 inhibition: which patient with chronic kidney disease should be treated in the future?
por: Neuen, Brendon L, et al.
Publicado: (2020)

Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy?
por: Egi, Moritoki, et al.
Publicado: (2009)

The impact of early hypoglycemia and blood glucose variability on outcome in critical illness
por: Bagshaw, Sean M, et al.
Publicado: (2009)

Estimating baseline kidney function in hospitalized adults with acute kidney injury
por: Larsen, Thomas, et al.
Publicado: (2022)

Findings of Sodium-Glucose Cotransporter-2 Inhibitor Kidney Outcome Trials Applied to a Canadian Chronic Kidney Disease Population: A Retrospective Cohort Study
por: Yi, Tae Won, et al.
Publicado: (2022)

Renal outcomes according to renal replacement therapy modality and treatment protocol in the ATN and RENAL trials
por: Naorungroj, Thummaporn, et al.
Publicado: (2022)

Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data From the CANVAS Program
por: Neuen, Brendon L., et al.
Publicado: (2018)

Sodium–glucose cotransporter 2 inhibitors: renal outcomes according to baseline albuminuria
por: Delanaye, Pierre, et al.
Publicado: (2021)

Significance of blood glucose variability in the early phase for predicting survival in acutely ill patients with glucose intolerance
por: Hoshino, M, et al.
Publicado: (2010)

Glucose Variability
por: Service, F. John
Publicado: (2013)

Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib
por: Lawson McLean, Aaron
Publicado: (2023)

Continuous Glucose Monitoring in Patients Following Simultaneous Pancreas–Kidney Transplantation: Time in Range and Glucose Variability
por: Dmitriev, Ilya V., et al.
Publicado: (2023)

Human Glucose Transporters in Renal Glucose Homeostasis
por: Sędzikowska, Aleksandra, et al.
Publicado: (2021)

Urinalysis and pre-renal acute kidney injury: time to move on
por: Schneider, Antoine G, et al.
Publicado: (2013)

Significance of day-to-day glucose variability in patients after acute coronary syndrome
por: Miyoshi, Machiko, et al.
Publicado: (2021)

A Renal Olfactory Receptor Aids in Kidney Glucose Handling
por: Shepard, Blythe D., et al.
Publicado: (2016)

Triglyceride-glucose index is significantly associated with the risk of hyperuricemia in patients with diabetic kidney disease
por: Li, Qiuhong, et al.
Publicado: (2022)

Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes
por: Neuen, Brendon L., et al.
Publicado: (2020)

Glucose variability and ICU outcome
por: Todi, S, et al.
Publicado: (2011)

Comparison of glucose variability measures
por: Bhattacharyya, M, et al.
Publicado: (2011)

Significance of the suppression of blood glucose variability in acutely ill severe patients with glucose intolerance evaluated by means of bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2008)

Association of Net Ultrafiltration Rate With Mortality Among Critically Ill Adults With Acute Kidney Injury Receiving Continuous Venovenous Hemodiafiltration: A Secondary Analysis of the Randomized Evaluation of Normal vs Augmented Level (RENAL) of Renal Replacement Therapy Trial
por: Murugan, Raghavan, et al.
Publicado: (2019)

Glycemic variability is complex - is glucose complexity variable?
por: van Hooijdonk, Roosmarijn TM, et al.
Publicado: (2012)

Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma
por: Imai, Hisao, et al.
Publicado: (2020)

Variable Classifications of Glycemic Index Determined by Glucose Meters
por: Lin, Meng-Hsueh Amanda, et al.
Publicado: (2010)

Interaction Effect of Baseline Serum Glucose and Early Ischemic Water Uptake on the Risk of Secondary Hemorrhage After Ischemic Stroke
por: Nawabi, Jawed, et al.
Publicado: (2021)

Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply
por: Mårtensson, Johan, et al.
Publicado: (2023)

Role of sodium‐glucose transporters in glucose uptake of the intestine and kidney
por: Harada, Norio, et al.
Publicado: (2012)

Hyperoncotic Albumin Solution in Continuous Renal Replacement Therapy Patients
por: O'Brien, Zachary, et al.
Publicado: (2022)

Clinical significance of serum glucose to lymphocyte ratio as a prognostic marker in peritoneal dialysis patients
por: Chen, Jiexin, et al.
Publicado: (2023)

Blood glucose variability, measured as mean absolute glucose, strongly depends on the frequency of blood glucose level measurements
por: Harmsen, RE, et al.
Publicado: (2011)

Renal Glucose Handling: Impact of chronic kidney disease and sodium-glucose cotransporter 2 inhibition in patients with type 2 diabetes
por: Ferrannini, Ele, et al.
Publicado: (2013)

Variability of capillary blood glucose monitoring measured on home glucose monitoring devices
por: Kotwal, Narendra, et al.
Publicado: (2012)

Continuous glucose monitoring to assess glucose variability in type 3c diabetes
por: Lee, Victoria T. Y., et al.
Publicado: (2022)

Trimming the fat: is there a health economic case for the use of new lipid-lowering drugs in chronic kidney disease? A scoping review
por: Gallagher, Alexandra, et al.
Publicado: (2021)

A Lower Baseline Urinary Glucose Excretion Predicts a Better Response to the Sodium Glucose Cotransporter 2 Inhibitor
por: Hwang, You-Cheol, et al.
Publicado: (2019)

Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus
por: Pratley, Richard E., et al.
Publicado: (2018)

Glucose Variability: How Does It Work?
por: Klimontov, Vadim V., et al.
Publicado: (2021)

The prognostic role of hyperglycemia and glucose variability in covid-related acute respiratory distress Syndrome
por: Lazzeri, Chiara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fad2stj86gtn1on140j133v2p8